Healthcare provider profile · identity verified

Pradeep K Pradhan, MD

Internal Medicine · DANVILLE, VA · NPI 1568465854

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	952	296
Amlodipine Besylate	Amlodipine Besylate	685	222
Metoprolol Succinate	Metoprolol Succinate	397	115
Lisinopril	Lisinopril	390	121
Metformin Hcl	Metformin Hcl	387	122
Omeprazole	Omeprazole	370	122
Levothyroxine Sodium	Levothyroxine Sodium	365	99
Pantoprazole Sodium	Pantoprazole Sodium	311	102
Rosuvastatin Calcium	Rosuvastatin Calcium	299	102
Gabapentin	Gabapentin	292	88
Allopurinol	Allopurinol	272	76
Hydrochlorothiazide	Hydrochlorothiazide	252	83
Simvastatin	Simvastatin	236	71
Losartan Potassium	Losartan Potassium	217	71
Jardiance	Empagliflozin	215	49
Clonazepam	Clonazepam	214	41
Eliquis	Apixaban	211	38
Benazepril Hcl	Benazepril Hcl	178	45
Trazodone Hcl	Trazodone Hcl	176	55
Ropinirole Hcl	Ropinirole Hcl	174	44
Carvedilol	Carvedilol	158	55
Metoprolol Tartrate	Metoprolol Tartrate	157	50
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	149	44
Alprazolam	Alprazolam	145	29
Meloxicam	Meloxicam	139	52
Furosemide	Furosemide	137	56
Fluticasone Propionate	Fluticasone Propionate	129	62
Sertraline Hcl	Sertraline Hcl	129	47
Famotidine	Famotidine	116	36
Potassium Chloride	Potassium Chloride	116	39
Finasteride	Finasteride	112	31
Tamsulosin Hcl	Tamsulosin Hcl	107	35
Albuterol Sulfate Hfa	Albuterol Sulfate	105	49
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	33
Montelukast Sodium	Montelukast Sodium	85	30
Lorazepam	Lorazepam	83	11
Triamcinolone Acetonide	Triamcinolone Acetonide	83	52
Chlorthalidone	Chlorthalidone	81	24
Clopidogrel	Clopidogrel Bisulfate	81	30
Irbesartan	Irbesartan	81	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	24
Ezetimibe	Ezetimibe	70	25
Mirtazapine	Mirtazapine	70	26
Valsartan	Valsartan	70	21
Escitalopram Oxalate	Escitalopram Oxalate	69	30
Alendronate Sodium	Alendronate Sodium	68	23
Xarelto	Rivaroxaban	68	14
Synthroid	Levothyroxine Sodium	66	18
Mounjaro	Tirzepatide	65	17
Pravastatin Sodium	Pravastatin Sodium	65	21
Breo Ellipta	Fluticasone/Vilanterol	63	13
Spironolactone	Spironolactone	63	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	60	17
Citalopram Hbr	Citalopram Hydrobromide	57	13
Tizanidine Hcl	Tizanidine Hcl	56	29
Paroxetine Hcl	Paroxetine Hcl	53	14
Buspirone Hcl	Buspirone Hcl	52	14
Ramipril	Ramipril	50	13
Venlafaxine Hcl Er	Venlafaxine Hcl	46	15
Ibuprofen	Ibuprofen	45	19
Meclizine Hcl	Meclizine Hcl	45	25
Pioglitazone Hcl	Pioglitazone Hcl	45	15
Torsemide	Torsemide	45	14
Hydralazine Hcl	Hydralazine Hcl	44	13
Trulicity	Dulaglutide	44	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	43	15
Diclofenac Sodium	Diclofenac Sodium	43	17
Ozempic	Semaglutide	43	13
Glimepiride	Glimepiride	41	17
Methylprednisolone	Methylprednisolone	41	38
Azelastine Hcl	Azelastine Hcl	40	20
Entresto	Sacubitril/Valsartan	40	suppressed
Azithromycin	Azithromycin	39	37
Duloxetine Hcl	Duloxetine Hcl	39	15
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	12
Tramadol Hcl	Tramadol Hcl	39	17
Lansoprazole	Lansoprazole	36	suppressed
Prednisone	Prednisone	36	11
Wixela Inhub	Fluticasone Propion/Salmeterol	36	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	35	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	30
Cephalexin	Cephalexin	34	30
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	16
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Celecoxib	Celecoxib	32	12
Metformin Hcl Er	Metformin Hcl	31	13
Donepezil Hcl	Donepezil Hcl	30	suppressed
Glipizide	Glipizide	30	12
Ondansetron Hcl	Ondansetron Hcl	30	20
Verapamil Er	Verapamil Hcl	30	suppressed
Atenolol	Atenolol	29	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Nystatin	Nystatin	28	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Glipizide Er	Glipizide	27	12
Hydroxyzine Hcl	Hydroxyzine Hcl	27	15
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Baclofen	Baclofen	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Myrbetriq	Mirabegron	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Linzess	Linaclotide	22	12
Labetalol Hcl	Labetalol Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Amoxicillin	Amoxicillin	17	16
Enalapril Maleate	Enalapril Maleate	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Ondansetron Odt	Ondansetron	17	13
Colchicine	Colchicine	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Naproxen	Naproxen	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Diazepam	Diazepam	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Methimazole	Methimazole	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Cefdinir	Cefdinir	11	11
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Fluconazole	Fluconazole	11	11
Levofloxacin	Levofloxacin	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error